NCT01523236View on ClinicalTrials.gov

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Mometasone furoate

50 mcg/actuation Nasal Spray

DRUG

Nasonex®

50 mcg/actuation Nasal Spray

DRUG

Placebo

Nasal Spray

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01523236 - Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation | Biotech Hunter | Biotech Hunter